Application

18182242 · MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2

Filed 2023-03-10 · Granted · Patent 12679897 (2026-07-14) The official file ↗The patent and its PDF ↗ · Art unit 1674 · Examiner Ruixiang Li Typical · CPC C07K 16/2863 · GALAXY BIOTECH, LLC. · Marshall, Gerstein & Borun LLP (Amgen)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

25.9 mo

to disposition 40.1 mo

Statutes raised

101 102 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.